重症脓毒症年轻幸存者的长期生存情况
该回顾性队列研究纳入2003至2011年七家三级医院ICU收治的脓毒症患者,将409例小于45岁且存活出院的脓毒症患者与818例年龄、性别匹配的无脓毒症感染性疾病住院患者进行比较。脓毒症组出院后6个月、1年、3年死亡率分别为0.7%对0%、4.5%对0.7%、7.9%对1.2%,均显著高于对照组(P<0.001)。多因素Cox回归显示脓毒症与死亡风险升高相关(HR 3.79,95%CI 2.27-6.32)。超过24个月后脓毒症不再是独立死亡风险因素(HR 1.79,95%CI 0.67-4.79)。作者认为慢性基础合并症可能解释脓毒症患者的超额死亡。
要点
- 小于45岁重症脓毒症出院幸存者6个月、1年、3年死亡率分别为0.7%、4.5%、7.9%,对照组分别为0%、0.7%、1.2%(P<0.001)。
- 校正年龄、Charlson合并症指数、卒中史和充血性心力衰竭后,脓毒症与死亡风险升高相关(HR 3.79,95%CI 2.27-6.32)。
- 出院24个月后,脓毒症不再是独立死亡风险因素(HR 1.79,95%CI 0.67-4.79)。
- 作者认为慢性基础合并症可能解释脓毒症患者的超额死亡。
适用人群与场景
- 2003至2011年七家三级医院ICU收治的脓毒症患者中,小于45岁且存活出院者409例。
- 对照组为年龄、性别匹配的818例无脓毒症感染性疾病患者,选自内科或外科住院患者。
研究设计与关键结果
- 研究类型为回顾性队列研究,纳入409例小于45岁重症脓毒症出院幸存者,与818例年龄、性别匹配的无脓毒症感染性疾病患者比较。
- 脓毒症组与对照组中位年龄分别为31岁和32岁。
- 出院后6个月、1年、3年死亡率脓毒症组分别为0.7%、4.5%、7.9%,对照组分别为0%、0.7%、1.2%(P<0.001)。
- 多因素Cox回归校正年龄、Charlson合并症指数、卒中史和充血性心力衰竭后,脓毒症与死亡风险升高相关(HR 3.79,95%CI 2.27-6.32)。
- 以24个月为界标点后,脓毒症不是独立死亡风险因素(HR 1.79,95%CI 0.67-4.79)。
- 死因分析提示慢性基础合并症可能解释脓毒症患者的超额死亡。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为小于45岁重症脓毒症出院幸存者长期死亡风险仍较高,出院后24个月内死亡率最高,慢性基础合并症可能解释超额死亡。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Sepsis remains a disease with a high mortality rate. The study goal was to assess long-term survival of severe sepsis in young patients.
DESIGN: Retrospective cohort study.
SETTING: Patients admitted with sepsis to ICUs in seven tertiary hospitals between 2003 and 2011.
PATIENTS: A total of 409 patients less than 45 years who survived to hospital discharge were age and sex matched with 818 patients with infectious disease without sepsis selected from internal medicine or surgical department admissions.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: The median age in sepsis patients and the comparison group was 31 and 32 years, respectively. The proportions of patients surviving after hospital discharge were significantly lower in the sepsis group compared with the control group; among survivors, 6-month, 1-year, and 3-year mortality rates were 0.7% versus 0%, 4.5% versus 0.7%, 7.9% versus 1.2%, and 10.8% versus 1.8%, respectively (p < 0.001 for all). In a multivariate Cox proportional hazards regression model, sepsis was associated with an increased risk of mortality (hazard ratio, 3.79; 95% CI, 2.27-6.32), while controlling for age, Charlson Comorbidity Index, history of stroke, and congestive heart failure. Past the 24-month landmark, sepsis was not found to be an independent risk for mortality (hazard ratio, 1.79; 95% CI, 0.67-4.79). Based on cause of death analysis, chronic underlying comorbidities might explain the excess mortality in patients with sepsis.
CONCLUSIONS: Young patients experiencing an episode of severe sepsis continue to be at higher risk of long-term mortality. The highest mortality rates were observed during the first 24 months following discharge.
参考来源
- Abu-Kaf H, Mizrakli Y, Novack V, et al. Long-Term Survival of Young Patients Surviving ICU Admission With Severe Sepsis. Crit Care Med. 2018. PMID: 29742586. doi:10.1097/CCM.0000000000003205
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。